The mTOR inhibitor sirolimus has been found to be effective in lymphatic malformations that were refractory to standard treatment 27, 28 priligy (dapoxetine)
The mTOR inhibitor sirolimus has been found to be effective in lymphatic malformations that were refractory to standard treatment 27, 28 priligy (dapoxetine)